India's pharmaceutical sector sees robust 10% growth, fueled by North American and domestic sales.
India's pharmaceutical sector saw a 10% year-on-year growth in the second quarter of FY25, driven by strong performances in North America and domestically. Chronic therapies increased by 9%, and the healthcare sector showed a 17.6% year-on-year rise in top-line revenue. A positive outlook is projected for the coming three years, with promising developments in biosimilars, GLP-1, and peptides.
2 months ago
14 Articles
Articles
Further Reading
You have 9 free stories remaining this month. Subscribe anytime for unlimited access.